Back to today’s briefing

Story perspectives

FDA Weighs Lifting Warnings on Hormone Therapies for Menopause

7/24/2025

50 4

Summary

Story summary

The FDA is considering lifting black box warnings on certain hormone therapies for menopause, which currently highlight risks such as strokes and breast cancer. Experts believe new research indicates these treatments can be safe and beneficial when initiated early. Women facing menopause symptoms are encouraged to discuss effective management strategies with their healthcare providers.

1 of 1

Story summary

The FDA is considering lifting black box warnings on certain hormone therapies for menopause, which currently highlight risks such as strokes and breast cancer. Experts believe new research indicates these treatments can be safe and beneficial when initiated early. Women facing menopause symptoms are encouraged to discuss effective management strategies with their healthcare providers.